In financial accounting, a balance sheet is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity.

Amplia Therapeutics Limited Balance Sheet Statement - Assets

As of 31 Mar 2022, The total current assets of Amplia Therapeutics Limited (ASX:ATX) was around $16,532,854 which consisted of $14,608,581 of Cash, no Inventory and $1,843,003 of Net receivables. Current assets represent all the assets of a company that are expected to be conveniently sold, consumed, used, or exhausted through standard business operations within one year.

All amounts in AUD

Cash
$14.61M
Current assets
$16.53M
Total assets
$24.48M

The latest balance sheet of Amplia Therapeutics Limited also showed $12,915 of Property Plant Equipment and no Good will. Also there were $7,937,932 of Intangible assets and no Other assets. The total assets including current and Intangibles/Deferred Long Term Asset Charges were $24,483,701.

Amplia Therapeutics Limited Balance Sheet Statement - Liabilities

ATX's latest annual results shows the balance sheet has $368,894 of Accounts Payable. Also there were no Short/Long term debt, $2,100,473 of Long term debt, $161,286 of Other Current liabilities and $530,180 of Total Current Liabilities. Current liabilities are a company's short-term financial obligations that are due within one year or within a normal operating cycle.

Account payable
$368.89k
Current liabilities
$530.18k
Total liabilities
$2.64M

As per the 31 Mar 2022's annual report of Amplia Therapeutics Limited, the total liabilities were $2,636,063.

ATX Balance Sheet Statement - Stock Holder Equity

Stockholders' equity, also referred to as shareholders' equity, is the remaining amount of assets available to shareholders after all liabilities have been paid. It is calculated either as a firm's total assets less its total liabilities or alternatively as the sum of share capital and retained earnings less treasury shares. Stockholders' equity might include common stock, paid-in capital, retained earnings and treasury stock.

The latest Balance sheet of Amplia Therapeutics Limited showed the total stock holder equity was $21,847,638 which consisted of $151,507,741 of Common stocks, $-128,618,452 of Retained earnings and $-1,041,651 of Other stock holder equity.

ATX Balance Sheet Statement History

Following table shows the history of balance sheet for Amplia Therapeutics Limited (ATX).

31 Mar 2022 31 Mar 2021 31 Mar 2020 31 Mar 2019
Cash 14.61M 1.85M 1.11M 1.24M
Net Receivables 1.84M 1M 34.23k -
Inventory - - - -
Total Current Assets 16.53M 2.94M 1.18M 1.25M
Property Plant Equipment 12.91k 5.47k 797 1.6k
Good Will - - - -
Intangible Assets 7.94M 7.94M 7.94M 7.94M
Other Assets - - - -
Deferred Long Term Asset Charges - - - -
Total Assets 24.48M 10.88M 9.12M 9.19M
Accounts Payable 368.89k 486.68k 474.07k 394.13k
Short/Long Term Debt - - - -
Other Current Liabilities 161.29k 52.45k 10.61k 10.61k
Long Term Debt 2.1M - - -
Other Liabilities 5.41k - - -
Total Current Liabilities 530.18k 539.13k 510.62k 526.86k
Total Liabilities 2.64M 539.13k 510.62k 526.86k
Common Stock 151.51M 136.55M 132.9M 130.95M
Retained Earnings -128.62M -125.21M -122.93M -120.92M
Treasury Stock -1.04M -1.01M -1.37M -1.36M
Other Stockholder Equity -1.04M -1.01M -1.37M -1.36M
Total Stockholder Equity 21.85M 10.34M 8.61M 8.66M
Net Tangible Assets 13.91M 2.4M 667.83k 726.54k

Amplia Therapeutics Limited (ASX:ATX) Balance Sheet Statement FAQ

1. How much Cash Amplia Therapeutics Limited has on their balance sheet?

As of 31 Mar 2022, Amplia Therapeutics Limited (ASX:ATX) has $14,608,581 of Cash.

2. What's the long term debt of Amplia Therapeutics Limited?

As per the latest Balance sheet of Amplia Therapeutics Limited (ASX:ATX), it has $2,100,473 of Long term debt.

3. How much share holder equity does Amplia Therapeutics Limited has?

The Amplia Therapeutics Limited (ASX:ATX)'s balance sheet shows that it has $21,847,638 of Total stock holder equity.